Stuart Anderson – författare

The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia – at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire.

Pharmacopoeias, Drug Regulation, and Empires traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardized pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalization of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardization became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones.

Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.

The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia – at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire.

Pharmacopoeias, Drug Regulation, and Empires traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardized pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalization of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardization became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones.

Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.

Research into the delivery and organisation of health care is a vital component in the improvement of health services. A wide range of disciplines and methods needs to be deployed to address research questions in this field. This unique reader brings together thirty examples of high-quality SDO research using a range of disciplines, including organisational studies, epidemiology, sociology, history, health economics, anthropology and policy studies, illustrating the use of qualitative and quantitative approaches and primary and secondary research. Expert editorial commentary on each section highlights different themes and methodological issues.

The reader covers six main areas of research:

This book is a companion volume to Studying the Organisation and Delivery of Health Services: Research Methods also published by Routledge (2001). It makes top-quality, empirical and secondary research readily accessible to health service managers and health care professionals who are interested in research, to health service researchers and to undergraduate and postgraduate students following courses in health and health management studies.

Research into the delivery and organisation of health care is a vital component in the improvement of health services. A wide range of disciplines and methods needs to be deployed to address research questions in this field. This unique reader brings together thirty examples of high-quality SDO research using a range of disciplines, including organisational studies, epidemiology, sociology, history, health economics, anthropology and policy studies, illustrating the use of qualitative and quantitative approaches and primary and secondary research. Expert editorial commentary on each section highlights different themes and methodological issues.

The reader covers six main areas of research:

This book is a companion volume to Studying the Organisation and Delivery of Health Services: Research Methods also published by Routledge (2001). It makes top-quality, empirical and secondary research readily accessible to health service managers and health care professionals who are interested in research, to health service researchers and to undergraduate and postgraduate students following courses in health and health management studies.

First Published in 2001. This is the first book to combine research methods from a range of social science disciplines and apply them to health service research. Health service delivery and organisation is a growing and increasingly important area of research not readily amenable to methods used to evaluate health technologies.

First Published in 2001. This is the first book to combine research methods from a range of social science disciplines and apply them to health service research. Health service delivery and organisation is a growing and increasingly important area of research not readily amenable to methods used to evaluate health technologies.

Classes of socio-technical hazards allow a characterization of the risk in technology innovation and clarify the mechanisms underpinning emergent technological risk. Emerging Technological Risk provides an interdisciplinary account of risk in socio-technical systems including hazards which highlight:

·         How technological risk crosses organizational boundaries,

·         How technological trajectories and evolution develop from resolving tensions emerging between social aspects of organisations and technologies and

·         How social behaviour shapes, and is shaped by, technology.

Addressing an audience from a range of academic and professional backgrounds, Emerging Technological Risk is a key source for those who wish to benefit from a detail and methodical exposure to multiple perspectives on technological risk. By providing a synthesis of recent work on risk that captures the complex mechanisms that characterize the emergence of risk in technology innovation, Emerging Technological Risk bridges contributions from many disciplines in order to sustain a fruitful debate.

Emerging Technological Risk is one of a series of books developed by the Dependability Interdisciplinary Research Collaboration funded by the UK Engineering and Physical Sciences Research Council.